Koenig Matthew A
Continuum (Minneap Minn). 2018 Dec;24(6):1588-1602. doi: 10.1212/CON.0000000000000665.
This article reviews the management of cerebral edema, elevated intracranial pressure (ICP), and cerebral herniation syndromes in neurocritical care.
While corticosteroids may be effective in reducing vasogenic edema around brain tumors, they are contraindicated in traumatic cerebral edema. Mannitol and hypertonic saline use should be tailored to patient characteristics including intravascular volume status. In patients with traumatic brain injury who are comatose, elevated ICP should be managed with an algorithmic, multitiered treatment protocol to maintain an ICP of 22 mm Hg or less. Third-line ICP treatments include anesthetic agents, induced hypothermia, and decompressive craniectomy. Recent clinical trials have demonstrated that induced hypothermia and decompressive craniectomy are ineffective as early neuroprotective strategies and should be reserved for third-line management of refractory ICP elevation in severe traumatic brain injury. Monitoring for cerebral herniation should include bedside pupillometry in supratentorial space-occupying lesions and recognition of upward herniation in patients with posterior fossa lesions.
Although elevated ICP, cerebral edema, and cerebral herniation are interrelated, treatments should be based on the distinct pathophysiologic process. Focal lesions resulting in brain compression are primarily managed with surgical decompression, whereas global or multifocal brain injury requires a treatment protocol that includes medical and surgical interventions.
本文综述了神经重症监护中脑水肿、颅内压(ICP)升高及脑疝综合征的管理。
虽然皮质类固醇可能对减轻脑肿瘤周围的血管源性水肿有效,但在创伤性脑水肿中禁用。甘露醇和高渗盐水的使用应根据患者特征进行调整,包括血管内容量状态。对于昏迷的创伤性脑损伤患者,应采用算法化的多层治疗方案来管理升高的ICP,以将ICP维持在22 mmHg或更低。三线ICP治疗包括麻醉剂、诱导低温和减压颅骨切除术。最近的临床试验表明,诱导低温和减压颅骨切除术作为早期神经保护策略无效,应保留用于重度创伤性脑损伤中难治性ICP升高的三线管理。对脑疝的监测应包括幕上占位性病变的床边瞳孔测量以及后颅窝病变患者向上疝出的识别。
虽然ICP升高、脑水肿和脑疝相互关联,但治疗应基于不同的病理生理过程。导致脑受压的局灶性病变主要通过手术减压处理,而弥漫性或多灶性脑损伤则需要包括医学和手术干预的治疗方案。